Introducing dysfunctional Protein-Protein Interactome (dfPPI) – A platform for systems-level protein-protein interaction (PPI) dysfunction investigation in disease
Current Opinion in Structural Biology,
Journal Year:
2024,
Volume and Issue:
88, P. 102886 - 102886
Published: July 13, 2024
Protein-protein
interactions
(PPIs)
play
a
crucial
role
in
cellular
function
and
disease
manifestation,
with
dysfunctions
PPI
networks
providing
direct
link
between
stressors
phenotype.
The
dysfunctional
Protein-Protein
Interactome
(dfPPI)
platform,
formerly
known
as
epichaperomics,
is
newly
developed
chemoproteomic
method
aimed
at
detecting
dynamic
changes
the
systems
level
under
stressor-induced
perturbations
within
states.
This
review
provides
an
overview
of
dfPPIs,
emphasizing
novel
methodology,
data
analytics,
applications
research.
dfPPI
has
cancer
research,
where
it
identifies
integral
to
maintaining
malignant
phenotypes
discovers
strategies
enhance
efficacy
current
therapies.
In
neurodegenerative
disorders,
uncovers
critical
processes
stressor-specific
vulnerabilities.
Challenges,
including
complexity
potential
for
integration
other
omics
datasets
are
discussed.
platform
potent
tool
dissecting
biology
by
directly
informing
on
holds
promise
advancing
identification
therapeutics.
Language: Английский
Studying Target–Engagement of Anti-Infectives by Solvent-Induced Protein Precipitation and Quantitative Mass Spectrometry
Lorenzo Bizzarri,
No information about this author
Dominik Steinbrunn,
No information about this author
Thibaut Quennesson
No information about this author
et al.
ACS Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
10(12), P. 4087 - 4102
Published: Nov. 20, 2024
Antimicrobial
resistance
(AMR)
poses
a
serious
threat
to
global
health.
The
rapid
emergence
of
contrasts
with
the
slow
pace
antimicrobial
development,
emphasizing
urgent
need
for
innovative
drug
discovery
approaches.
This
study
addresses
critical
bottleneck
in
early
development
by
introducing
integral
solvent-induced
protein
precipitation
(iSPP)
rapidly
assess
target–engagement
lead
compounds
extracts
pathogenic
microorganisms
under
close-to-physiological
conditions.
iSPP
measures
change
stability
against
presence
ligands.
method
bacteria
builds
upon
established
SPP
procedures
and
features
optimized
denaturation
gradients
minimized
sample
input
amounts.
effectiveness
workflow
was
initially
demonstrated
through
multidrug
study.
Using
quantitative
mass
spectrometry
(LC-MS/MS),
we
successfully
identified
known
targets
seven
different
antibiotics
cell
four
AMR-related
pathogens:
three
Gram-negative
Escherichia
coli,
Klebsiella
pneumoniae,
Pseudomonas
aeruginosa
Gram-positive
bacterium
Staphylococcus
aureus.
ultimately
applied
demonstrate
derived
from
target-based
discovery.
We
employed
five
small
molecules
targeting
enzymes
2-C-methyl-d-erythritol
4-phosphate
(MEP)
pathway─a
promising
focus
anti-infective
development.
showcases
adaptability
efficiency
identifying
targets,
advancing
early-stage
AMR.
Language: Английский